Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Phase 1
Completed
- Conditions
- Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- John Byrd
- Target Recruit Count
- 36
- Registration Number
- NCT00201682
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath